Two large, prospective, randomized controlled studies showed that intensive insulin therapy in hyperglycemic patients in a surgical intensive care unit (ICU) resulted in a 50% reduction in mortality, along with several other benefits, including a reduction in the incidence of renal failure, septicemia and ICU neuropathy. This evidence concerns the gene INS and Sepsis.